<DOC>
	<DOCNO>NCT00004488</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine efficacy alendronate sodium treat osteopenia ( generalize bone density focal bone lesion ) patient Gaucher 's disease .</brief_summary>
	<brief_title>Phase II Randomized Study Alendronate Sodium Osteopenia Patients With Gaucher 's Disease</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double blind , placebo control study . All patient receive oral calcium carbonate cholecalciferol daily . Patients randomize receive oral alendronate sodium placebo daily 24 month . Patients follow every 6 month 2 year . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Gaucher Disease</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Calcium Carbonate</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Diagnosis type 1 Gaucher 's disease enzymatically proven acid beta glucosidase deficiency Must stable dose ( 860 U/kg/every 2 week ) alglucerase enzyme therapy ( Cerezyme Ceredase ) least 24 month Lumbar spine bone density mean age , sex , race Prior/Concurrent Therapy At least 6 month since prior medication directly affect skeletal metabolism include , limited , bisphosphonates , calcitonin , parathyroid hormone , estrogen Patient Characteristics Renal : No chronic renal failure ; No recurrent renal stone Esophageal : No history dysphagia ; No frequent heartburn ; No esophagitis require treatment Other : No untreated hyperthyroidism hypothyroidism ; No concurrent hyperparathyroidism ; No concurrent malignancy ; No history alcohol drug abuse ; Not pregnant ; Negative pregnancy test ; Fertile patient must use effective contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2000</verification_date>
	<keyword>Gaucher 's disease</keyword>
	<keyword>inborn error metabolism</keyword>
	<keyword>rare disease</keyword>
	<keyword>sphingolipidoses</keyword>
</DOC>